Evidence map›Paper›PMID 41654605›Full record

ArticleScientific reports2026

Pathways to lung cancer diagnosis and treatment among patients in Ethiopia: A qualitative study.

Nathan Estifanos, Gudina Egata, Adamu Addissie, Mirgissa Kaba, Rahel Argaw Kebede, Aschalew Worku, Amsalu Bitew, Mathewos Assefa, Biruk Habtamu, Selam Tesfaye and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nathan EstifanosSchool of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. estifanos9090@gmail.com.ORCID http://orcid.org/0000-0001-5598-2206
Gudina EgataSchool of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Adamu AddissieSchool of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Mirgissa KabaSchool of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Rahel Argaw KebedeSchool of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Aschalew WorkuSchool of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Amsalu BitewSchool of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Mathewos AssefaOncology Department, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Biruk HabtamuOncology Department, School of Medicine, College of Health Sciences, Haramaya University, Harar, Ethiopia.
Selam TesfayeOncology Department, School of Medicine, College of Health Sciences, Jimma University, Jimma, Ethiopia.
Negussie DeyessaSchool of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Late-stage presentation remains a major challenge for cancer control in low- and middle-income countries, driven by limited cancer care infrastructure, diagnostic constraints, and the lack of organized lung cancer screening programs. Therefore, this study explored the pathways of lung cancer diagnosis and treatment, as well as patients’ experiences throughout this journey in Ethiopia. This multicenter qualitative study in three tertiary hospitals involved interviews with 33 primary lung cancer patients who had started at least one treatment and were analyzed thematically, beginning with a deductive approach guided by the pathways to the treatment model and followed by inductive approaches to capture emerging patterns. Six sequential but nonlinear steps were identified along the diagnostic and treatment pathways. The journey began with symptom recognition and appraisal, yet none of the participants initially suspected cancer; most attributed their symptoms to minor illnesses. Many waited before seeking care, opting first for self-management through wait-and-see, home remedies, herbal treatments, or holy water. Care seeking was eventually triggered by worsening symptoms or family encouragement. Navigating the health system was complex, marked by multiple referrals ranging from 2 to 12 different health facilities, repeated misdiagnoses (especially tuberculosis), and inappropriate treatments, even among smokers. Diagnosis is often late, and communication of the diagnosis is frequently unclear, with little psychosocial support. Treatment initiation was further hindered by the limited availability of oncology services and long waiting times of 3 months to nearly 2 years. Financial burdens were profound; patients reported selling assets, borrowing money, and incurring significant debts that affected entire families. The time taken at every step—from symptom recognition to treatment initiation—contributes significantly to the high burden of late-stage lung cancer. Urgent multilevel interventions are needed, including enhancing public awareness of lung cancer, strengthening diagnostic capabilities, improving referral coordination, training healthcare providers in compassionate communication, expanding access to cancer care, and reducing the financial burden on patients. Additionally, given that traditional and religious institutions are widely trusted and frequently consulted, integrating them can support early detection and psychosocial care.

Indexed as

Lung NeoplasmsAdultAgedEarly Detection of CancerEthiopiaFemaleHumansMaleMiddle AgedPatient Acceptance of Health CareQualitative ResearchTreatment DelayEthiopiaLung cancerPatient experienceQualitative researchTime to diagnosisTreatment pathways

Identifiers

PMID41654605
PMCPMC12946188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.